Abstract
Since the beginning of the AIDS pandemic, gastrointestinal (GI) problems have been among the most common features of the disease. Despite the introduction of highly active antiretroviral therapy (HAART) in 1995 and 1996, most HIV-infected patients continue to have GI complications. The clinician must be able to diagnose and treat the opportunistic gastrointestinal infections and neoplasms that occur in the advanced AIDS patient, as well as the treatment-induced symptoms and non-HIV-related GI disorders that predominate in early HIV disease. This review addresses the GI manifestations of HIV, with particular emphasis on new developments in the era of highly effective therapy.
Similar content being viewed by others
References and Recommended Reading
Monkemuller KE, Call SA, Lazenby AJ, et al.: Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol 2000, 95:457–462. Report on an extremely well-done prospective study of the effect of highly active antiretroviral therapy (HAART) on gastrointestinal (GI) disease in HIV. The authors document the amazing decline in GI opportunistic processes after HAART, even in patients whose CD4 count did not appreciably increase.
Bini EJ, Cohen J: Impact of protease on the outcome of human immunodefiency virus-infected patients with chronic diarrhea. Am J Gastroenterol 1999, 94:3553–3559. Findings from this massive retrospective study confirm the dramatic improvement in symptoms and survival in AIDS patients with chronic diarrhea after HAART.
Weinert M, Grimes RM, Lynch DP: Oral manifestations of HIV infection. Ann Intern Med 1996, 125:485–496.
Wilcox CM, Monkemuller KE: Diagnosis and management of esophageal disease in the acquired immunodeficiency syndrome. South Med J 1998, 91:1002–1008.
Dieterich DT, Wilcox CM: Diagnosis and treatment of esophageal diseases associated with HIV Infection. Am J Gastroenterol 1996, 91:2265–2269.
Jacobsen JM, Spritzler J, Fox L, et al.: Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodefiency virus infection. J Infect Dis 1999, 180:61–67.
Wilcox CM: Esophageal strictures complicating ulcerating esophagitis in patients with AIDS. Am J Gastroenterol 1999, 94:339–343.
Bonacini M, Laine LA: Esophageal disease in patients with AIDS. Gastrointest Endosc Clin North Am 1998, 8:811–823.
Poles MA, Lew EA, Dieterich DT: Diagnosis and treatment of hepatic disease in patients with HIV. Gastroenterol Clin North Am 1997, 27:291–321. Although written in 1997, still one of the best reviews on this topic.
Orenstein R, Lagall-Salmon E: HIV treatment-associated hepatitis. AIDS Reader 1999, 9:339–346.
Benhamou Y, Bochet M, Thibault V, et al.: Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodefiency virus-infected patients. Hepatology 1999, 30:1302–1306.
Lesens O, Deschenes M, Steben M: Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection. J Infect Dis 1999, 179:1254–1258.
Perez-Olmeda M, Gonzalez J, Garcia-Samaniego J: Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C. J Acquir Immune Defic Syndr Hum Retrovirol 1999, 22:308–315.
Nash JA, Cohen SA: Gallbladder and biliary tract disease in AIDS. Gastroenterol Clin North Am 1997, 26:323–335.
Cello JP: AIDS-related biliary tract disease. Gastrointest Endosc Clin North Am 1998, 8:963–973. An excellent discussion of AIDS-related biliary tract disease by one of the pioneering researchers in the area.
Mahajani RH, Uzer MF: Cholangiopathy in HIV-infected patients. Clin Liver Dis 1999, 3:669–684.
Dassopoulos T, Ehrenpreis ED: Acute pancreatitis in human immunodeficiency virus-infected patients: a review. Am J Med 1999, 107:78–84. Short but comprehensive review of pancreatitis in HIV. Extremely well-written.
Amnocha AP, Sossenheimer M, Martin SP, et al.: Prevalence and predictors of severe acute pancreatitis in patients with acquired immune deficiency syndrome (AIDS). Am J Gastroenterol 1999, 94:784–789.
Argiris A, Usha M, Wilets I, et al.: Abnormalities of serum amylase and lipase in HIV-positive patients. Am J Gastroenterol 1999, 94:1248–1252.
Saab S, Rickman LS, Lyche KD: Ascites and the acquired immunodeficiency syndrome. Medicine 1996, 75:131–141. The definitive article on ascites and HIV. Superb discussion of peritoneal disease.
Gelman SF, Brandt LJ: Pneumatosis intestinalis and AIDS: a case report and review of the literature. Am J Gastroenterol 1998, 93:646–650.
Monkemuller KE, Wilcox CM: Diagnosis and treatment of colonic disease in AIDS. Gastrointest Dis AIDS 1998, 8:889–911. Comprehensive, well-referenced review of colonic disease in AIDS.
Barrett Wl, Callahan TD, Orkin BA: Perianal manifestations of human immunodeficiency virus infection. Dis Colon Rectum 1998, 41:606–612.
Brar HS, Gottesman L, Surawicz C: Anorectal pathology in AIDS. Gastrointest Endosc Clin North Am 1998, 8:913–915. A superior review of this common clinical problem.
Lacey HB, Wilson GE, Tilston P, et al.: A study of anal intraepithelial neoplasia in HIV positive homosexual men. Sex Transm Infect 1999, 75:172–177.
Goldie SJ, Kuntz KM, Weinstein MC, et al.: The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999, 281:1822–1829.
Lord, RN: Anorectal surgery in patients infected with human immunodeficiency virus: factors associated with delayed wound healing. Ann Surg 1997, 226:92–99.
Kartalija M, Sande MA: Diarrhea and AIDS in the era of highly active antiretroviral therapy. Clin Infect Dis 1999, 28:701–707. Excellent discussion of the changes in HIV-associated diarrhea in the HAART era. Succinct and extremely well-referenced.
Foudraine NA, Weverling GJ, van Gool T, et al.: Improvement of chronic diarrhea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS 1998, 12:35–51.
Carr A, Marriott D, Field A, et al.: Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 1998, 351:256–261.
Wanke CA, Gerrior J, Blais V, et al.: Successful treatment of diarrheal disease associated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus. J Infect Dis 1998, 178:1369–1372.
Cappell MS.: The pancreas in AIDS. Gastroenterol Clin North Am 1997, 26:337–365.
Lew EA, Poles MA, Dieterich DT: Diarrheal diseases associated with HIV infection. HIV Infect Gastrointest Tract 1997, 26:259–290.
Simon D: Evaluation of diarrhea in HIV-infected patients. Gastrointest Endosc 1998, 8:857–967.
Quinn TC: Diversity of Campylobacter species and its impact on patients infected with human immunodeficiency virus [editorial response]. Clinic Infect Dis 1997, 24:1114–1117.
Wildox MC, Chalasani N, Lazenby A, et al.: Cytomegalovirus colitis in acquired immunodeficiency syndrome: a clinical and endoscopic study. Gastrointest Endosc 1998, 48:39–43.
Savin CA, Clewley GS, Deayton JR, et al.: Shorter survival in HIV-positive patients with diarrhea who excrete adenovirus from the GI tract. J Med Virol 1999, 58:280–285.
Grohmann GS, Glass RI, Pereira HG, et al.: Enteric viruses and diarrhea in HIV-infected patients. N Engl J Med 1993, 329:14–20.
Hashmey R, Smith NH, Cron S, et al.: Cryptosporidiosis in Houston, Texas. Medicine 1997, 76:118–139.
Clark Douglas P: New insights in human cryptosporidiosis. Clin Microbiol Rev 1999, 12:554–563.
Smith NH, Cron S, Valdez LM, et al.: Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis 1998, 178:900–903.
Lambl BB, Federman M, Pleskow D, et al.: Malabsorption and wasting in AIDS patients with Microsporidia and pathogen-negative diarrhea. AIDS 1996, 10:739–744.
Wilcox CM, Monkemuller KE: The therapy of gastrointestinal infections associated with the acquired immunodeficiency syndrome. Aliment Pharmacol Ther 1997, 11:425–443.
Kotler Donald P: Characterization of intestinal disease associated with human immunodeficiency virus infection and response to antiretroviral therapy. J Infect Dis 1999, 179(suppl 3):S454-S456. Short but excellent discussion of pathogen-negative diarrhea and the role of HIV itself as a possible cause.
Wu CM, Davis F, Fishman EK: Radiologic evaluation of the acute abdomen in the patient with acquired immunodeficiency syndrome (AIDS): the role of CT scanning. Semin Ultrasound CT MRI 1998, 19:190–199.
Corley DA, Cello JP, Koch J: Evaluation of upper gastrointestinal track symptoms in patients infected with HIV. Am J Gastroenterol 1999, 94:2890–2896.
Endres JC, Salky BA: Laparoscopy in AIDS: gastrointestinal disease in AIDS. Gastrointest Endosc Clin North Am 1998, :975–990.
Wilson SE, Robinson G, Williams RA, et al.: Acquired immune deficiency syndrom (AIDS): indications for abdominal surgery, pathology, and outcome. Ann Surg 1989, 210:428–434.
Danzig JB, Brandt LJ, Reinus JF, et al.: Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol 1991, 86:715–718.
Rabkin CS, Testa MA, Huang J, et al.: Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS clinical trial group study participants. J Acquir Immune Defic Syndr Hum Retrovirol 1999, 21(suppl 1):S31-S33.
Greenwald DA, Brandt LJ: Gastrointestinal bleeding in AIDS. Gastrointest Endosc Clin North Am 1998, 8:933–938.
Bini EJ, Micale PL, Weinshel EH: Risk factors for rebleeding and mortality from acute upper gastrointestinal hemorrhage in human immunodeficiency virus infection. Am J Gastroenterol 1999, 94:358–363.
Cappell MS, Geller AJ: The high mortality of gastrointestinal bleeding in HIV-seropositive patients: a multivariate analysis of risk factors and warning signs of mortality in 50 consecutive patients. Am J Gastroenterol 1992, 87:815–824.
Chalasani N, Wilcox CM: Etiology and outcome of lower gastrointestinal bleeding in patients with AIDS. Am J Gastroenterol 1998, 93:175–178.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wallace, M.R., Brann, O.S. Gastrointestinal manifestations of HIV infection. Curr Gastroenterol Rep 2, 283–293 (2000). https://doi.org/10.1007/s11894-000-0020-1
Issue Date:
DOI: https://doi.org/10.1007/s11894-000-0020-1